CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
School of Pharmacy, Yantai University, Yantai, 264005, China.
Angew Chem Int Ed Engl. 2020 Feb 10;59(7):2634-2638. doi: 10.1002/anie.201911508. Epub 2020 Jan 9.
Herein, we report the design and synthesis of a mitochondria-specific, 808 nm NIR light-activated photodynamic therapy (PDT) system based on the combination of metal-organic frameworks (MOFs) and upconversion photochemistry with an organelle-targeting strategy. The system was synthesized through the growth of a porphyrinic MOF on Nd -sensitized upconversion nanoparticles to achieve Janus nanostructures with further asymmetric functionalization of the surface of the MOF domain. The PDT nanoplatform allows for photosensitizing with 808 nm NIR light, which could effectively avoid the laser-irradiation-induced overheating effect. Furthermore, mitochondria-targeting could amplify PDT efficacy through the depolarization of the mitochondrial membrane and the initiation of intrinsic apoptotic pathway. This work sheds light on the hybrid engineering of MOFs to combat their current limitations for PDT.
在此,我们报告了一种基于金属-有机框架(MOFs)和上转换光化学与细胞器靶向策略相结合的线粒体特异性、808nm 近红外光激活光动力疗法(PDT)系统的设计和合成。该系统通过在 Nd 敏化上转换纳米粒子上生长卟啉 MOF 来合成,以实现具有 MOF 域表面进一步不对称功能化的 Janus 纳米结构。PDT 纳米平台允许用 808nm 近红外光进行光敏化,这可以有效地避免激光照射引起的过热效应。此外,线粒体靶向可以通过线粒体膜去极化和启动内在凋亡途径来放大 PDT 效果。这项工作为 MOFs 的混合工程提供了思路,以克服其在 PDT 方面的当前局限性。